Global Digestive Aids Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Digestive Aids Market Insights, Forecast to 2034
Digestive aids are products, substances, or techniques used to support and improve the process of digestion within the human body.
Market Analysis and InsightsGlobal Digestive Aids Market
Global Digestive Aids market is expected to reach to US$ 1967 million in 2024, with a positive growth of %, compared with US$ 1845 million in 2022. Backed with the increasing demand from downstream industries, Digestive Aids industry is evaluated to reach US$ 4004.7 million in 2029. The CAGR will be 12.6% during 2024 to 2029.
Digestive aids are medications used to improve the functioning of the gastrointestinal tract, facilitate the digestion of food and relieve symptoms of indigestion. These medications are widely used in clinical practice, especially in the treatment of gastrointestinal problems, stomach ulcers, heartburn, gastroesophageal reflux disease (GERD) and other digestive disorders. Antacid medications such as proton pump inhibitors (PPIs) and H2 receptor antagonists (H2RAs) remain the mainstay of treatment for GERD and gastric ulcers. Although they are very effective, long-term use can lead to a number of side effects and safety concerns, so researchers are seeking safer alternatives. Probiotics and prebiotics are believed to be beneficial for gut health, improving the balance of intestinal flora and positively affecting digestion and the immune system. These products have become part of the market for digestive aids and new research continues to support their effectiveness. A number of natural herbs and herbal remedies are widely used to treat indigestion and gastrointestinal problems. These include turmeric, peppermint, wormwood and aloe vera. Researchers are delving into the efficacy and safety of these botanical medicines. Overall, the field of digestive aid medications is evolving, with researchers and doctors striving to find safer and more effective treatments, as well as a growing emphasis on the importance of personalised treatment and a healthy diet. In the future, as medical science continues to advance, we can expect to see more innovative and improved digestive aids and treatments.
Report Covers
This report presents an overview of global Digestive Aids market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Digestive Aids market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Roche Holding
Abbvie
Bayer
Pfizer
Biogen
Johnson & Johnson
Takeda Pharmaceutical
Amgen
Sanofi
Novozymes
Metagenics
Enzymedica
o., Ltd.
Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Yabao Pharmaceutical Group Co., Ltd.
ZhuZhou QianJin Pharmaceutical Co., Ltd.
Zhejiang Yatai Pharmaceutical Co., Ltd.
Zhejiang East-Asia Pharmaceutical Co., Ltd.
Guangdong Sunho Pharmaceutical Co., Ltd.
Cisen Pharmaceutical Co., Ltd.
Hunan Jingfeng Pharmaceutical Co., Ltd.
Tibet Aim Pharm. Inc.
Medifactia
Konsyl Pharmaceuticals,Inc
Segment by Type
Gastrointestinal Dynamics
Digestive Enzyme Drugs
Antacids
Antigastrics
Hospitals
Clinics
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Digestive Aids introduction, etc. Digestive Aids Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports’s Conclusions of Digestive Aids
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports
Market Analysis and InsightsGlobal Digestive Aids Market
Global Digestive Aids market is expected to reach to US$ 1967 million in 2024, with a positive growth of %, compared with US$ 1845 million in 2022. Backed with the increasing demand from downstream industries, Digestive Aids industry is evaluated to reach US$ 4004.7 million in 2029. The CAGR will be 12.6% during 2024 to 2029.
Digestive aids are medications used to improve the functioning of the gastrointestinal tract, facilitate the digestion of food and relieve symptoms of indigestion. These medications are widely used in clinical practice, especially in the treatment of gastrointestinal problems, stomach ulcers, heartburn, gastroesophageal reflux disease (GERD) and other digestive disorders. Antacid medications such as proton pump inhibitors (PPIs) and H2 receptor antagonists (H2RAs) remain the mainstay of treatment for GERD and gastric ulcers. Although they are very effective, long-term use can lead to a number of side effects and safety concerns, so researchers are seeking safer alternatives. Probiotics and prebiotics are believed to be beneficial for gut health, improving the balance of intestinal flora and positively affecting digestion and the immune system. These products have become part of the market for digestive aids and new research continues to support their effectiveness. A number of natural herbs and herbal remedies are widely used to treat indigestion and gastrointestinal problems. These include turmeric, peppermint, wormwood and aloe vera. Researchers are delving into the efficacy and safety of these botanical medicines. Overall, the field of digestive aid medications is evolving, with researchers and doctors striving to find safer and more effective treatments, as well as a growing emphasis on the importance of personalised treatment and a healthy diet. In the future, as medical science continues to advance, we can expect to see more innovative and improved digestive aids and treatments.
Report Covers
This report presents an overview of global Digestive Aids market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Digestive Aids market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Roche Holding
Abbvie
Bayer
Pfizer
Biogen
Johnson & Johnson
Takeda Pharmaceutical
Amgen
Sanofi
Novozymes
Metagenics
Enzymedica
o., Ltd.
Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Yabao Pharmaceutical Group Co., Ltd.
ZhuZhou QianJin Pharmaceutical Co., Ltd.
Zhejiang Yatai Pharmaceutical Co., Ltd.
Zhejiang East-Asia Pharmaceutical Co., Ltd.
Guangdong Sunho Pharmaceutical Co., Ltd.
Cisen Pharmaceutical Co., Ltd.
Hunan Jingfeng Pharmaceutical Co., Ltd.
Tibet Aim Pharm. Inc.
Medifactia
Konsyl Pharmaceuticals,Inc
Segment by Type
Gastrointestinal Dynamics
Digestive Enzyme Drugs
Antacids
Antigastrics
Segment by Application
Hospitals
Clinics
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Digestive Aids introduction, etc. Digestive Aids Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports’s Conclusions of Digestive Aids
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices